Routine imaging in post-operational PDAC vs symptomatic FU
A recent paper by Paul Andel, PhD-candidate of the Surgical Department at UMC Utrecht, was mentioned by Giovanni Marchegiani, Academic Pancreas Surgeon at the Hepato Pancreato Biliary (HPB) and Liver Transplant Surgery of the Padova University Hospital, on X:
“Recurrence after PDAC resection is sadly a fact.
EAHPBA study on 333 patients reveals routine imaging in post-operational PDAC vs. symptomatic FU. Prompt access chemotherapy = better survival.”
“Routine Imaging or Symptomatic Follow-Up After Resection of Pancreatic Adenocarcinoma”
Authors: Paul Andel, Iris van Goor,Simone Augustinus, Lois Daamen, Hjalmar van Santvoort, et al.
More posts featuring Giovanni Marchegiani.
Giovanni Marchegiani MD, PhD, is an Academic Pancreas Surgeon at the Hepato Pancreato Biliary (HPB) and Liver Transplant Surgery of the Padova University Hospital. He also practices as a surgeon at Verona Integrated University Hospital Company.
Dr. Marchegiani is an Editor for BJS Open and serves as the Chairperson of the European-African Hepato-Pancreato-Biliary Association (E-AHPBA). He is also a Faculty Member of United European Gastroenterology (UEG).
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023